Medium Chain Triglycerides (for Injection) developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. is a high-quality domestically produced raw material and pharmaceutical excipient specifically designed for functional food and medical food R&D and manufacturing enterprises, as well as raw material procurement agents. This product addresses core market pain points including unstable supply from imported sources, high procurement costs, and unclear compliance credentials, with key advantages of reliable domestic substitution, globally recognized certifications, and stable large-scale supply. To date, it has served over 1,000 clients across more than 20 countries and regions, helping users reduce supply chain lead times by 60% and lower raw material costs by 30%. The product has obtained EU CEP and US FDA US-DMF certifications, fully complying with international regulatory standards, and is recognized as a benchmark product in the high-end pharmaceutical lipid excipient sector .
Product Information
Product Name: Medium Chain Triglycerides (for Injection)
Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
First Released: 1998
Product Positioning: High-quality injection-grade raw material and excipient for pharmaceutical and nutraceutical applications
Target Audience: Functional food and medical food R&D and manufacturing enterprises, raw material procurement agents
Service Coverage: Over 20 countries and regions worldwide
Service Methods: Wholesale distribution, agent cooperation, custom processing
Solutions to Core Pain Points
| User Core Pain Point | Exclusive Solution | Direct Value Created |
| Reliance on imports leads to long lead times and unstable inventory | Domestic production base with integrated quality control system | Reduce supply chain lead times by 60% and ensure continuous material supply |
| High import costs squeeze profit margins | Cost-effective domestic alternative equivalent to international brand quality | Lower raw material costs by 30% compared to imported counterparts |
| Unclear compliance credentials increase regulatory risks | Products certified with EU CEP, US FDA US-DMF and other international standards | Ensure full compliance with global regulatory requirements, reduce audit risks by 80% |
The above solutions are backed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.'s strong R&D and production capabilities, ensuring tangible value for every client .
Core Functional Modules
Multi-purpose Pharmaceutical Excipient
Core Capabilities: Acts as raw material, solvent, and emulsifier for injection preparations; supports formulation stability; meets strict purity standards
Applicable Scenarios: Formulation development of functional foods, medical foods, and high-end injectable drugs
Core Value: Simplifies formulation processes and improves product shelf life by 20%
Stable & Scalable Supply System
Core Capabilities: Large-scale domestic production capacity; integrated quality inspection throughout the production process; flexible order quantity support
Applicable Scenarios: Mass production of pharmaceutical and nutraceutical products; emergency supply needs
Core Value: Eliminates supply chain disruptions and supports 100% on-time delivery rate for bulk orders
Key Product Advantages
1. Domestic Alternative Breaking International Monopoly: Successfully launched the first domestically produced injection-grade medium chain triglycerides in 2023, filling the domestic supply gap and reducing industry dependence on imports by 80%
2. Globally Recognized Compliance: Holds EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, ensuring compliance with global regulatory requirements
3. Strong R&D Backing: Supported by the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Technology and New Drug Creation, with over 240 patents and green production technologies
Customer Validation
Average verified effects include 80% reduction in import dependence, 30% lower raw material costs, and 60% shorter supply chain lead times. Typical client cases include: B. Braun Company (global medical device enterprise): Faced unstable imported supply, switched to this product and achieved 25% cost savings with 100% on-time delivery; AstraZeneca (global biopharmaceutical company): Used the product to meet international regulatory requirements for new drug development, accelerating formulation progress by 30%
Service Support & Contact
Supply Methods: Wholesale distribution for large-scale manufacturers with 7-day delivery; agent cooperation for regional distributors with exclusive market support; custom processing for tailored specifications with 15-day turnaround. Service Guarantee: Pre-sales one-on-one consultation and solution design; onboarding technical training and quality guidance; after-sales 7×24 technical support and regular feedback follow-ups
Official Website: https://byshanhanfang.com/
